Ad is loading...
FLIAX vs TOLZX
FLIAX vs TOLZX Comparison
Open Charts FLIAX vs TOLZX
First Sentier American Listed Infras Ins
Price$10.20
Change+$0.02 (+0.20%)
VolumeN/A
Net Assets3.62M
DWS RREEF Global Infrastructure R6
Price$16.62
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets885.08M
FLIAX vs TOLZX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
TOLZX has more cash in the bank: 885M vs. FLIAX (3.62M). TOLZX pays higher dividends than FLIAX: TOLZX (2.21) vs FLIAX (1.96). FLIAX was incepted earlier than TOLZX: FLIAX (4 years) vs TOLZX (11 years). FLIAX (8.80) is less costly to investors than TOLZX (1.04). FLIAX is a more actively managed with annual turnover of: 82.30 vs. TOLZX (30.00). TOLZX has a lower initial minimum investment than FLIAX: TOLZX (0) vs FLIAX (1000000). TOLZX annual gain was more profitable for investors over the last year : 12.54 vs. FLIAX (7.09).
| FLIAX | TOLZX | FLIAX / TOLZX | |
| Total Expense Ratio | 0.75 | 1.01 | 74% |
| Annual Report Gross Expense Ratio | 8.80 | 1.04 | 846% |
| Fund Existence | 4 years | 11 years | - |
| Gain YTD | 3.343 | 10.086 | 33% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.62M | 885M | 0% |
| Annual Yield % from dividends | 1.96 | 2.21 | 89% |
| Returns for 1 year | 7.09 | 12.54 | 57% |
| Returns for 3 years | -6.46 | 3.24 | -200% |
| Returns for 5 years | N/A | 24.36 | - |
| Returns for 10 years | N/A | 34.63 | - |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BWET | 11.74 | 0.20 | +1.78% |
| Breakwave Tanker Shipping ETF | |||
| VKI | 8.52 | 0.06 | +0.71% |
| Invesco Advantage Municipal Income Trust II | |||
| AOM | 44.01 | 0.05 | +0.11% |
| iShares Core 40/60 Moderate Allc ETF | |||
| ETHO | 55.30 | 0.01 | +0.02% |
| Amplify Etho Climate Leadership U.S. ETF | |||
| BIB | 39.63 | -1.61 | -3.90% |
| ProShares Ultra Nasdaq Biotechnology | |||